Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/02/20 → 8/10/21 |
Funding
- Sanofi Pasteur MSD Limited: £1,649.82
- Sanofi Pasteur MSD Limited: £206,376.45
Respiratory pathogen-specific airway immunity assessment
- Dhaliwal, Kevin (Principal Investigator)
- Bradley, Mark (Co-investigator)